OBJECTIVE: To report our experience with repeat microvascular decompression (MVD) for hemifacial @entity2473 (HFS) in @entity1 who have failed their first operation. METHODS: The authors describe 41 redo MVDs for HFS in 36 @entity1 performed over a 3 year period. Seven @entity1 underwent early re-operation after an @entity2103 . Eight @entity1 underwent early re-operation for clinical failure. Eighteen @entity1 underwent late re-operation for @entity2473 recurrence long after their original MVD. Eight MVDs were performed on @entity1 who had already undergone at least two prior operations. RESULTS: Twenty four @entity1 experienced complete @entity2473 resolution (70.6%), eight @entity1 had near total resolution (23.5%), and two @entity1 failed re-operation (5.9%). Two @entity1 were lost to follow up (5.6%). A favourable outcome was reported by 82.4% of @entity1 at a mean follow up interval of 18 months. A total of 91.7% of @entity1 50 years of age or younger were cured at follow up versus 59.1% of @entity1 older than 50 (p = 0.04). @entity1 undergoing early re-operation were significantly more likely to be cured or improved than @entity1 undergoing late re-operation (p = 0.03). CONCLUSIONS: Repeat MVD for HFS is effective in experienced hands. Younger @entity1 respond better to repeat MVD. Late repeat MVD for HFS is a reasonable treatment option, although results are less favourable than for early re-operation.

Repeat microvascular decompression for hemifacial XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'Patients'] @entity2473 :: ('MESH:D013035', 'Disease') :: ['spasm'] @entity2103 :: ('MESH:D005155', 'Disease') :: ['aborted seventh nerve decompression']
@entity2473 :: (MESH:D013035,Disease) :: ['spasm']
